| Takeda to submit EPO rival in the USA next year - Pharma Times |
|
|
Pharma TimesSubject to feedback from the agency, they will pursue a New Drug Application for dialysis patients, “while continuing to evaluate the non-dialysis ...Affymax hopes to ask for Hematide approval in 2011 BusinessWeekAffymax and Takeda Announce Preliminary U.S. Registration Strategy for ... read more |